Explore By Subject Area   
Return Home
Menu

Lead Editorial

Conference Forum Joins Fierce Life Sciences

Conference Forum Joins Fierce Life Sciences

The Conference Forum has been acquired by Questex LLC, the parent company of Fierce Healthcare & Life Sciences.

Read More

Featured Editorial

How Merck Research Labs Is Evolving its Global Clinical Supply to Meet the Demands of Newer Modalities

Read More

Biogen on Digital Innovations to Increase Trial Access and Enhance Patient Experiences

Read More

What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help

Read More

How CMOs can Leverage AI to Streamline Clinical Development

Read More

TrialHub Wins DPHARM Idol Disrupt 2025

Read More

Editorial by Category

Modernizing Clinical Trial Operations

View All
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
End-to-End Innovation: How Technology is Transforming Every Step of the Clinical Trial Value Stream
End-to-End Innovation: How Technology is Transforming Every Step of the Clinical Trial Value Stream
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
Conference Forum Joins Fierce Life Sciences
Conference Forum Joins Fierce Life Sciences

Immuno-Oncology and Cell Therapy

View All
Targeting Tumor Recurrence to Improve Long-Term Survival for Patients
Targeting Tumor Recurrence to Improve Long-Term Survival for Patients
Overcoming ADC Challenges of Toxicity and Drug Resistance with a Granzyme B Payload
Overcoming ADC Challenges of Toxicity and Drug Resistance with a Granzyme B Payload
Report: Cancer Research Institute's 2025 Cancer Immunotherapy Insights and Impact
Report: Cancer Research Institute's 2025 Cancer Immunotherapy Insights and Impact
IO360º Convenes Technology and Solution Providers to Address Key Capabilities to Advance IO Drug Development
IO360º Convenes Technology and Solution Providers to Address Key Capabilities to Advance IO Drug Development

Drug Delivery

View All
Ophthalmic Implants: Current and Future Technologies in Long-Acting Drug Delivery
Ophthalmic Implants: Current and Future Technologies in Long-Acting Drug Delivery
PODD: Partnership Opportunities in Drug Delivery 2025 Recap
PODD: Partnership Opportunities in Drug Delivery 2025 Recap
Drug Delivery to the Brain: Engineering Precision Across Novel Modalities
Drug Delivery to the Brain: Engineering Precision Across Novel Modalities
Conference Forum Joins Fierce Life Sciences
Conference Forum Joins Fierce Life Sciences

Patients as Partners in Clinical Research and Patient Access

View All
How Sponsors Can Be Better Partners to Rural Sites Bringing Clinical Research to Patients
How Sponsors Can Be Better Partners to Rural Sites Bringing Clinical Research to Patients
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
Questex Announces the 2026 Patients as Partners® in Clinical Research Meeting with Keynotes and Topics
Questex Announces the 2026 Patients as Partners® in Clinical Research Meeting with Keynotes and Topics
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign

Biotech CMO/R&D Leadership

View All
Questex Announces 2026 Chief Medical Officer Summit 360° Agenda and Keynotes
Questex Announces 2026 Chief Medical Officer Summit 360° Agenda and Keynotes
How Biotech CMOs Can Prepare for M&A with Pharma
How Biotech CMOs Can Prepare for M&A with Pharma
Conference Forum Joins Fierce Life Sciences
Conference Forum Joins Fierce Life Sciences
Morphic Therapeutic’s Acquisition by Eli Lilly From the CMO Perspective
Morphic Therapeutic’s Acquisition by Eli Lilly From the CMO Perspective

Community-Based Clinical Trials

View All
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
What Does Clinical Trial Tokenization Mean for Real-World Data and Long-Term Patient Follow-Up?
How Pharma Can Work More Effectively with Hospitals to Grow Clinical Trials
How Pharma Can Work More Effectively with Hospitals to Grow Clinical Trials
Insights from Javara’s Medical Director: Enhancing Clinical Research through Smarter EHR Utilization
Insights from Javara’s Medical Director: Enhancing Clinical Research through Smarter EHR Utilization
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign
How Agios Partnered with the Sickle Cell Community to Design the RISE UP Phase 2/3 Trial and Awareness Campaign

Women Leadership in Biotech

View All
Commercializing Therapies Requires Patient-Centricity and Advocacy
Commercializing Therapies Requires Patient-Centricity and Advocacy
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Genentech’s Approach to Partnership and Licensing is Driving Innovation
How Genentech’s Approach to Partnership and Licensing is Driving Innovation

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.